Lei Deng

2.0k total citations
33 papers, 1.5k citations indexed

About

Lei Deng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lei Deng has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Lei Deng's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers) and Immune Cell Function and Interaction (5 papers). Lei Deng is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers) and Immune Cell Function and Interaction (5 papers). Lei Deng collaborates with scholars based in China, United States and Iran. Lei Deng's co-authors include Beicheng Sun, Runqiu Jiang, Junwei Tang, Yu Xie, Ke Wang, Xuehao Wang, Han Zhuo, Wen‐Ming Chu, Jie Ji and Yun Chen and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Lei Deng

32 papers receiving 1.5k citations

Peers

Lei Deng
Zhengxin Wang China
Pu Li China
Ming-hua Zhu China
Jane J. Sohn United States
Shengming Dai China
Dongdong Lu China
Yaguang Weng China
Ming Lü China
Zhengxin Wang China
Lei Deng
Citations per year, relative to Lei Deng Lei Deng (= 1×) peers Zhengxin Wang

Countries citing papers authored by Lei Deng

Since Specialization
Citations

This map shows the geographic impact of Lei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Deng more than expected).

Fields of papers citing papers by Lei Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Deng. The network helps show where Lei Deng may publish in the future.

Co-authorship network of co-authors of Lei Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Deng. A scholar is included among the top collaborators of Lei Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Deng. Lei Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yanfang, Peixian Zhang, Lei Deng, et al.. (2024). Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System. Anti-Cancer Agents in Medicinal Chemistry. 24(13). 1016–1028. 1 indexed citations
2.
3.
Zhang, Peixian, et al.. (2020). <p>LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy</p>. Cancer Management and Research. Volume 12. 1681–1692. 16 indexed citations
4.
Wu, Chen, Lei Deng, Han Zhuo, et al.. (2020). Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection. Journal of Cellular and Molecular Medicine. 24(17). 10216–10222. 26 indexed citations
5.
Jiang, Runqiu, Junwei Tang, Yun Chen, et al.. (2017). The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nature Communications. 8(1). 15129–15129. 288 indexed citations
6.
Wang, Xiaochen, Junwei Tang, Rong Huang, et al.. (2016). LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway. Cell Death and Disease. 7(3). e2130–e2130. 52 indexed citations
7.
Hou, Jiajie, Lei Deng, Han Zhuo, et al.. (2015). PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma. Journal of Molecular Cell Biology. 7(4). 338–350. 12 indexed citations
8.
Hu, Shuai, Xiaofeng Wu, Bo Zhou, et al.. (2014). IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 140(6). 883–893. 37 indexed citations
9.
Tang, Jinhai, Han Zhuo, X Zhang, et al.. (2014). A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death and Disease. 5(12). e1549–e1549. 173 indexed citations
10.
Chen, Shenglin, et al.. (2014). Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. Biomedicine & Pharmacotherapy. 69. 277–284. 51 indexed citations
11.
Chen, Chen, Jiajie Hou, Zhe Lin, et al.. (2013). A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma. Cellular and Molecular Immunology. 10(4). 349–359. 12 indexed citations
12.
Hou, Jiajie, Yongxiang Xia, Runqiu Jiang, et al.. (2013). PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB. Journal of Hepatology. 60(2). 306–312. 27 indexed citations
13.
Ma, Xuelei, Lei Liu, Xiaoxiao Liu, et al.. (2012). Prognostic Role of MicroRNA-21 in Non-small Cell Lung Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 13(5). 2329–2334. 21 indexed citations
14.
Hou, Jiajie, Juan Xu, Runqiu Jiang, et al.. (2012). Estrogen-Sensitive PTPRO Expression Represses Hepatocellular Carcinoma Progression by Control of STAT3. Hepatology. 57(2). 678–688. 77 indexed citations
15.
Jiang, Runqiu, Lei Deng, Liang Zhao, et al.. (2011). miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males. Clinical Cancer Research. 17(17). 5593–5603. 64 indexed citations
16.
17.
Li, Guoqiang, Xiaofeng Wu, Feng Zhang, et al.. (2010). Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 137(4). 695–703. 13 indexed citations
18.
Zhang, Qian, Qi Shen, Joseph Celestino, et al.. (2009). Enhanced estrogen-induced proliferation in obese rat endometrium. American Journal of Obstetrics and Gynecology. 200(2). 186.e1–186.e8. 61 indexed citations
19.
Jiang, Runqiu, Yongxiang Xia, Jun Li, et al.. (2009). High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancer. International Journal of Cancer. 126(5). 1263–1274. 56 indexed citations
20.
Sun, Beicheng, et al.. (2008). The level of oncogene H-Ras correlates with tumorigenicity and malignancy. Cell Cycle. 7(7). 934–939. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengxin Wang Breakdown of academic impact, for papers by Pu Li Breakdown of academic impact, for papers by Ming-hua Zhu Breakdown of academic impact, for papers by Jane J. Sohn Breakdown of academic impact, for papers by Shengming Dai Breakdown of academic impact, for papers by Dongdong Lu Breakdown of academic impact, for papers by Yaguang Weng Breakdown of academic impact, for papers by Ming Lü
Rankless by CCL
2026